Aubrey Rankin

Insider Reports History

Location
Newark, CA
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aubrey Rankin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 321,611 $2,402,434 $7.47 15 Mar 2022 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Revance Therapeutics, Inc. Director Common Stock 154,302 $1,152,636 $7.47 15 Mar 2022 The Rankin Irrevocable Trust
Revance Therapeutics, Inc. Director Common Stock 94,091 $702,860 $7.47 15 Mar 2022 Direct

Insider Reports Filed by Aubrey Rankin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122019718-rankin-aubrey-2022-03-15 Revance Therapeutics, Inc. 15 Mar 2022 1 -$21,664 4 Director 17 Mar 2022, 17:50
/report/000147929021000171-rankin-aubrey-2021-12-03 Revance Therapeutics, Inc. 03 Dec 2021 1 +$432,876 4 President, Innovation & Tech, Director 06 Dec 2021, 19:34
/report/000147929021000152-rankin-aubrey-2021-08-15 Revance Therapeutics, Inc. 15 Aug 2021 2 -$375,432 4 President, Innovation & Tech, Director 17 Aug 2021, 18:20
/report/000147929021000141-rankin-aubrey-2021-07-28 Revance Therapeutics, Inc. 28 Jul 2021 2 -$1,632,960 4 President, Innovation & Tech, Director 30 Jul 2021, 20:57
/report/000147929021000139-rankin-aubrey-2021-07-26 Revance Therapeutics, Inc. 26 Jul 2021 1 -$1,645,953 4 President, Innovation & Tech, Director 28 Jul 2021, 21:48